VACONTIL

This brand name is authorized in Cyprus, Hong Kong, Malta, Singapore

Active ingredients

The drug VACONTIL contains one active pharmaceutical ingredient (API):

1 Loperamide
UNII 6X9OC3H4II - LOPERAMIDE

By binding to opiate receptors in the gut wall, loperamide hydrochloride reduces propulsive peristalsis, increases intestinal transit time and enhances resorption of water and electrolytes. Loperamide increases the tone of the anal sphincter, which helps reduce faecal incontinence and urgency.

Read about Loperamide

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
VACONTIL Capsule, hard Υπουργείο Υγείας (CY) MPI, EU: SmPC
VACONTIL Tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A07DA03 Loperamide A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07D Antipropulsives → A07DA Antipropulsives
Discover more medicines within A07DA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: HK Department of Health Drug Office Identifier(s): 40800, 42905
Country: MT Medicines Authority Identifier(s): AA032/07201, AA032/07202
Country: SG Health Sciences Authority Identifier(s): 05587P

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.